Integrative analysis of the inter-tumoral heterogeneity of triple-negative breast cancer

Triple-negative breast cancers (TNBC) lack estrogen and progesterone receptors and HER2 amplification, and are resistant to therapies that target these receptors. Tumors from TNBC patients are heterogeneous based on genetic variations, tumor histology, and clinical outcomes. We used high throughput...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Alec M., Mitra, Mithun, Boymoushakian, Lari, Coller, Hilary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081411/
https://www.ncbi.nlm.nih.gov/pubmed/30087365
http://dx.doi.org/10.1038/s41598-018-29992-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081411/
https://www.ncbi.nlm.nih.gov/pubmed/30087365
http://dx.doi.org/10.1038/s41598-018-29992-5

Ejemplares similares